Home
News
Create
Screeners
Insights
Bansisons Tea Industries
12.
58
0.00
(0.00%)
Market Cap
₹8.00 Cr
PE Ratio
-1.48
Industry
Consumer Goods
Buy
Sell
Company Performance:
1D
0.00%
1M
-5.41%
6M
-7.57%
1Y
+124.64%
5Y
+211.39%
View Company Insights
Latest news about Bansisons Tea Industries
Novyra Pharmachem reports ₹537.38 lakh loss in FY26
3 days ago
Novyra Pharmachem Limited reported a widened net loss of ₹537.38 lakh for FY26, compared to ₹6.36 lakh in FY25, on revenue of ₹10.44 lakh. To address accumulated losses of ₹570.79 lakh, the Board approved a capital reduction scheme of ₹5.42 crore, reducing paid-up capital from ₹633 lakh to ₹90.43 lakh by cancelling shares at a 1:7 ratio. The scheme, subject to NCLT and shareholder approval, aims to restructure the capital base without affecting shareholding percentages.
Novyra Pharmachem Board Approves Capital Reduction Proposal
May 16, 2026
Novyra Pharmachem Limited Further Reschedules Board Meeting to April 29, 2026
Apr 25, 2026
Novyra Pharmachem Limited Submits Q4FY26 Dematerialization Certificate
Apr 11, 2026
Novyra Pharmachem Limited Conducts Independent Directors Meeting on March 20, 2026
Mar 20, 2026
More news about Bansisons Tea Industries
06
Feb 26
Novyra Pharmachem Limited Appoints Anilkumar Mohanbhai Amreliya as Additional Executive Director
Novyra Pharmachem Limited appointed Anilkumar Mohanbhai Amreliya as Additional Director (Executive Director) effective February 6, 2026, following board approval. The new director brings over 25 years of sales and marketing experience and will serve until the next Annual General Meeting. The company has confirmed full regulatory compliance with SEBI requirements for the appointment.
26
Jan 26
Novyra Pharmachem Limited Reports Q3 FY26 Net Loss of ₹1.15 Lakhs
Novyra Pharmachem Limited (formerly Bansisons Tea Industries) reported a net loss of ₹1.15 lakhs for Q3 FY26 ended December 31, 2025, compared to ₹0.88 lakhs loss in Q3 FY25. The company generated no operational revenue during the quarter, with total expenses of ₹1.15 lakhs. For the nine-month period, the net loss increased to ₹1.82 lakhs from ₹1.34 lakhs in the previous year, despite other income of ₹6.31 lakhs. The Board approved these results on January 26, 2026.
30
Dec 25
Bansisons Tea Industries Shareholders Approve Name Change to Novyra Pharmachem
Bansisons Tea Industries has successfully completed its postal ballot process with unanimous shareholder approval for its transformation into Novyra Pharmachem Limited. All three resolutions received 100% approval from 35 participating shareholders representing 805,000 votes, enabling the company's strategic pivot from tea operations to pharmaceutical manufacturing and research activities.
24
Dec 25
Bansisons Tea Industries Gets New CIN After Gujarat Office Relocation Approval
Bansisons Tea Industries Limited has successfully completed its registered office relocation from West Bengal to Gujarat with a new CIN L15520GJ1987PLC171085 effective December 24, 2025. The company received initial approval from Regional Director Kolkata on November 28, 2025, and final CIN change approval from MCA on December 24, 2025, with proper disclosure made to BSE under SEBI regulations.
22
Dec 25
Bansisons Tea Industries Clarifies Audit Compliance for FY2020-21 Financial Results
Bansisons Tea Industries Limited clarified to BSE that its statutory auditors issued an unmodified audit opinion for FY2020-21 with no qualifications, making the Declaration on Impact of Audit Qualifications non-applicable. The company achieved a turnaround with net profit of ₹7.89 lakhs versus previous year's loss of ₹1.79 lakhs, while maintaining revenue of ₹15.00 lakhs. The non-submission was described as inadvertent, and the company resubmitted financial results to ensure compliance.
16
Dec 25
Bansisons Tea Industries Reports 89% Decline in Net Profit for FY22
Bansisons Tea Industries Limited reported a sharp 89% decline in net profit to ₹338.46 for FY22 compared to ₹7,886.52 in FY21. While revenue remained stable at ₹150.00, total expenses surged 68% to ₹185.36, primarily due to higher employee costs and operational expenses. The company received an unmodified audit opinion and clarified compliance matters with BSE regarding audit report submissions.
22
Nov 25
Bansisons Tea Industries' Independent Director Mamy Ghosh Resigns, Citing Pre-occupation
Mrs. Mamy Ghosh has resigned from her position as Independent Director of Bansisons Tea Industries Limited, effective November 19, 2025, citing pre-occupation. The company has initiated necessary procedures to process the resignation. This change will impact the board's composition, and the company may begin the process of appointing a new Independent Director.
Bansisons Tea Industries
12.
58
0.0
(0.0%)
1 Year Returns:
+124.64%
Industry Peers
Tata Consumer Products
1,149.30
(+
0.
46
%)
CCL Products
1,067.70
(-
0.
97
%)
Andrew Yule & Company
23.55
(+
1.
03
%)
McLeod Russel
72.35
(-
1.
99
%)
Goodricke Group
180.00
(-
0.
03
%)
United Nilgiri Tea
514.95
(-
1.
76
%)
Jay Shree Tea & Industries
87.29
(+
1.
36
%)
The Peria Karamalai Tea & Produce
802.20
(+
2.
35
%)
Neelamalai Agro Industries
3,300.00
(0.0%)
Gillanders Arbuthnot
90.00
(-
2.
26
%)
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/ Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation
IPO
Cyclical Trend
Events Calendar